Page 1,515«..1020..1,5141,5151,5161,517..1,5201,530..»

Dragon splashes down in Pacific with time-critical experiments – SpaceFlight Insider

Posted: July 6, 2017 at 5:44 am

Derek Richardson

July 3rd, 2017

The CRS-11 Dragon capsule re-enters Earths atmosphere. Photo Credit: Jack Fischer / NASA

SpaceXs CRS-11 Dragon capsule splashed down at 8:12 a.m. EDT (12:12 GMT) on July 3, 2017, in the Pacific Ocean just off the coast of Baja California after some 28 days attached to the International Space Station.

After being unberthed using the robotic Canadarm2, the craft was moved to a location some 33 feet (10 meters) below the Destiny laboratory module. It was officially released at 2:41 a.m. EDT (6:41 GMT) on July 3 by Expedition 52 astronauts Jack Fischer and Peggy Whitson of NASA.

The CRS-11 Dragon capsule is positioned for release beneath the ISS. Photo Credit: Jack Fischer / NASA

Dragons been an incredible spacecraft, Fischer said after release. I could even say it was slathered in awesome sauce. This baby has had almost no problems, which is an incredible feat considering its the first reuse of a Dragon vehicle.

The CRS-11 Dragon capsule pressure vessel was the same one used during the CRS-4 mission in 2014.

And the science weve done oh my, the science, Fischer said. Most of the 6,000 pounds [2,700 kilograms] of cargo carried was science, and almost all of the return cargo are precious samples for discoveries we cant wait to see.

Fischer explained that Dragon also brought up various external experiments too, including an external platform for science, a neutron star analyzer and an experimental solar array that was rolled out like a party horn on New Years Eve.

The science on this mission has been non-stop, and we think the scientists will be extremely happy with the volumes of data we gathered for them up here in space in our floating world-class laboratory we call home, Fischer said. For the whole SpaceX team, thank you for building such a great vehicle and for finding us some good weather today to allow us to bring home the science on time. Godspeed and fair winds, Dragon-11.

The spacecraft had originally been planned to splash down on July 2, but due to a forecast of unacceptable sea conditions at the recovery zone, mission managers decided on June 30 to postpone the capsules departure from the station.

Three separate departure burns were performed by the Dragon capsule once the robotic arm released the spacecraft. This gradually pushed the vehicle away from the outpost and outside the 656-foot (200-meter) Keep-Out Sphere (KOS).

Some five hours later, Dragon, using its Draco thrusters, performed a 10-minute de-orbit burn. Minutes after that, its trunk, which is not recoverable, was jettisoned.

Moments after being released by the ISS crew, the CRS-11 Dragon capsule begins its journey back to Earth. Photo Credit: Jack Fischer / NASA

A few minutes before splashing down, the capsule released drogue chutes to slow the capsule a bit and to keep a specific attitude for the three main parachutes to bedeployed. Once that occurred, along with a successful splashdown, it ensured a successful mission for the first re-flight of a commercial spacecraft to and from the ISS.

Now that Dragon is back on Earth and on a recovery ship, it will now be transported to the port of Los Angeles to offload time-sensitive cargo. The most notable include the Fruit Fly Lab-02 experiment, the Systemic Therapy of NELL-1 for osteoporosis study, and the Cardiac Stem Cells experiment.

The Fruit Fly Lab-02 experiment aims to understand the effects of prolonged microgravity exposure on the heart. According to NASA, because flies are small, have a well-known genetic makeup, and age rapidly, thatmakes them good models for heart function studies.

For the Systemic Therapy of NELL-1 for osteoporosis study, a group of rodents were used as models to test a drug that can rebuild bone and block additional bone density loss. It is hoped that this can help reduce bone density loss for astronauts on extended stays in space. Additionally, it can potentially help people with osteoporosis.

According to NASA, in-flight countermeasures, like exercise, can prevent bone density loss from getting worse, but nothing on Earth or in space can restore bone density.

Finally, the Cardiac Stem Cells experiment aims to analyze how microgravity affects stem cells and factors that govern stem cell activity. NASA says the study focuses on cardiac stem cell functions and has numerous biomedical and commercial applications.

The CRS-11 Dragon was launched June 3 from Kennedy Space Centers Launch Complex 39A in Florida. After a two-day rendezvous profile, the capsule was berthed to the Earth-facing port of the Harmony module on June 5.

The next Dragon mission will be CRS-12 on Aug. 10, 2017. It is unclear if this capsule will also be a pre-flown vessel.

Video courtesy of NASA

Tagged: CRS-11 Dragon Expedition 52 International Space Station Lead Stories NASA SpaceX

Derek Richardson has a degree in mass media, with an emphasis in contemporary journalism, from Washburn University in Topeka, Kansas. While at Washburn, he was the managing editor of the student run newspaper, the Washburn Review. He also has a blog about the International Space Station, called Orbital Velocity. He met with members of the SpaceFlight Insider team during the flight of a United Launch Alliance Atlas V 551 rocket with the MUOS-4 satellite. Richardson joined our team shortly thereafter. His passion for space ignited when he watched Space Shuttle Discovery launch into space Oct. 29, 1998. Today, this fervor has accelerated toward orbit and shows no signs of slowing down. After dabbling in math and engineering courses in college, he soon realized his true calling was communicating to others about space. Since joining SpaceFlight Insider in 2015, Richardson has worked to increase the quality of our content, eventually becoming our managing editor.

Follow this link:
Dragon splashes down in Pacific with time-critical experiments - SpaceFlight Insider

Posted in Florida Stem Cells | Comments Off on Dragon splashes down in Pacific with time-critical experiments – SpaceFlight Insider

A New Method for Making Stem Cells – Live Science

Posted: July 6, 2017 at 5:44 am

Scientists have found a new way of creating stem cells, which are cells that have the ability to turn into any type of tissue, using mouse cells. If the method works for human cells, it could ultimately be used to create tissue for people who need organ transplants, and to study diseases such as cancer.

The new method involves exposing cells taken from a mouse spleen to an acidic environment. After doing this, the scientists found they had created cells that were "pluripotent" capable of turning into most types of cells in the body, including those found in the lungs, muscle, bone, blood, skin or nervous system. The researchers called the stem cells they made "STAP cells" (an abbreviation for stimulus-triggered acquisition of pluripotency).

If the findings are replicated, "this result has the potential to be very significant," said Linzhao Cheng, a professor of medicine and oncology at the Johns Hopkins University School of Medicine, who was not involved in the research. [Video: STAP cells develop into an embryo]

Researchers in Japan first demonstrated the ability to makestem cellsfrom adult cells in 2006. This method uses viruses to insert new genes into adult cells, and produces cells calledinduced pluripotent stem cells(iPSCs).

But the new method of using acid doesn't require manipulating the cells' DNA, and may even be faster, researchers said.

The study not only shows that STAP cells offer an alternative way to generate stem cells for regenerative medicine, but also that they could help scientists learn about how tumors develop in cancer, Cheng told LiveScience.

Reprogramming cells

Normally, once cells in the body have become specialized for example, by becoming spleen cells they can no longer change course and develop into other types of cells. One goal of stem cell research is to find ways to reset adult cells, so that they can change course and grow into whatever tissue a person might need. That could mean a replacement of heart tissue damaged by a heart attack, or a new lung kidney to replace one ravaged by cancer.

Common wisdom holds that in order to make cells revert to their unspecialized state, researchers must either transfer the cell nucleus, or add a complex cocktail of substances that control how DNA gets made into proteins.

"I asked, can it be done without manipulating the nucleus?" Haruko Obokata of the RIKEN Center for Developmental Biology in Japan, leader of the research described online today (Jan. 29) in two papersin the journal Nature, told reporters.

Studies of plants have shown that a stressful environment can reprogram cells into an immature state. And, from this state, the cells can develop into an entirely new plant. But no one had reprogrammed animal cells in that way. [Inside Life Science: Once Upon a Stem Cell]

Obokata and her colleagues developed a new method to reprogram adult mouse cells. They took spleen cells from 1-week-old mice and bathed the cells in acidic fluid, at human body temperature, for 25 minutes.

They found that after the acid treatment, the cells indeed reverted to a pluripotent state like that seen in embryonic stem cells.The researchers used the same method to convert cells from brain, skin, muscle, fat, bone marrow, lung and liver tissues into stem cells, successfully.

The scientists tested the cells' potential by injecting them into mouse embryos that were already growing, but still at a very early stage of development. The researchers found these embryos developed into healthy mice that were "chimaeras," meaning they contained genetic material from both the STAP cells and the original cells of the embryo.

In a second study, the researchers found the STAP cells could develop into not only into the cells of the mouse embryo, but also into the cells of its placenta a strong demonstration of the cells' potential to develop into different cell types.

In addition, the scientists showed that STAP cells could be converted into self-renewing stem cells similar to embryonic stem cells.

Way of the future?

Compared with the time it takes to perform the current method, of creating iPSCs, the new method is much quicker, Obokata said.

In addition to the acidic treatment, the researchers tested whether other stresses such as squeezing the cells, heating them or depriving them of nutrients could also coax mature cells into becoming pluripotent. Initial findings suggest that some of these other stresses could have the same effect as the acidic treatment, the researchers said.

Paul Frenette, a stem cell biologist at Albert Einstein College of Medicine in New York who had no role in the study, called the new method "very exciting."

Many scientists have been spending a lot of effort on finding ways to reprogram cells, so achieving this by simply changing the acidity of the environment is remarkable, Frenette told LiveScience.

Other labs will try to replicate the findings in mice, and ultimately in human cells. The new method is"very easy to do, so we will see how quickly it's reproduced," Frenette said.

Editor's Note: This story was updated at 2:53 p.m. ET Jan. 29, to specify that cells from brain, muscle and other tissues were also converted to STAP cells.

Follow Tanya Lewis on Twitterand Google+.Follow us @livescience, Facebook& Google+. Original article onLiveScience.

Read more from the original source:
A New Method for Making Stem Cells - Live Science

Posted in New York Stem Cells | Comments Off on A New Method for Making Stem Cells – Live Science

Sex For Reproduction May Be Obsolete Within 30 Years Thanks To New Technology, Professor Predicts – Medical Daily

Posted: July 6, 2017 at 5:44 am

Sure, the main purpose of sex isprocreation, but according to one researcher, in as little as 30 years, we may have more efficient and cheaper ways of making babiesthangood ole fashioned intercourse. According to Hank Greely, the director of StanfordLaw Schools Center for Law and Biosciences, human reproductionmay become automated faster than you realize.

Greely believes that within three decades, people will no longer have sex as a way to reproduce, and instead relyongenetically edited embryos grown from skin-derived stem cells, not the combination of an egg or sperm, The Independent reported. According to Greely, this processensures that the embryo is free from any devastating genetic diseases, and wouldalso be cheaper in the long run because of the money it would save in healthcare over the years. Whats more, Greely predicts that couples would be able to choose other genetic traits in their children, such as physical features and intelligence.

Read: What Is A Three Parent IVF Technique? Worlds First Baby Born Using DNA From Three Parents, But How?

I dont think were going to be able to say this embryo will get a 1550 on its two-part SAT, Greely said this week at Aspen Ideas Festival, Quartz reported, But, this embryo has a 60% chance of being in the top half, this embryo has a 13% chance of being in the top 10%I think thats really possible.

The idea may soundfar-out, but according to Quartz, it already happens on a much smaller and limited scale as a way to prevent certain diseases. Although extremely expensive at the moment, advances in stem cell technology willhelp to drive down the cost. In addition, the amount that the government would save on not having to take care of sick babies would also make this more cost-efficient.

Making babies from skin cellsrather than a traditional egg fertilized with spermmaysound like its straight out of Hollywood, butthetechnology is quickly advancing. The skin cells, one from the mother and the other from the father, are coaxed into becoming an egg or sperm cell, The New York Times reported. This also means that one day same-sex couples may be able to have biologically related children. So far, vitro gametogenesis (IVG), or making sex cells from stem cells, has only worked on mice.

Theres also the worry that being able to genetically manipulate your offspring may lead to a eugenicssituation where less favorable traits get written out of the human genome forever. However, Greely also believes this is not the case.

This is not designer babies or super babies, said Greely, Quartz reported. This is selecting embryos. You take two people, all you can get out of a baby is what those two people have.

Just because well no longer need sex for procreation doesnt mean the activity is going out of fashion anytime soon. It's agreat way to createfuture generations, and sexis also good for your physical and mental health, as well as keeping couples together.

See Also:

Designer Babies: The Truth Behind Preimplantation Genetic Diagnosis

Scientists Edit Human Embryo Genes For First Time Ever: A Step Toward Disease-Free Future?

See the original post:
Sex For Reproduction May Be Obsolete Within 30 Years Thanks To New Technology, Professor Predicts - Medical Daily

Posted in New York Stem Cells | Comments Off on Sex For Reproduction May Be Obsolete Within 30 Years Thanks To New Technology, Professor Predicts – Medical Daily

These Scientists Have a Plan To Cheat Death. Will It Work? – NBCNews.com

Posted: July 6, 2017 at 5:44 am

Resurrecting the dead may be out of the question, but new research points to better ways to care for patients with critical brain injuries.Jun.29.2017 / 4:32 PM ET Conceptual close up image of a synapse. Science Picture Co / Getty Images Conceptual close up image of a synapse. Science Picture Co / Getty Images

Nothing is as certain as death. Yet humans have come up with ways to push it further and further. The heart stops beating? Do CPR. The lungs fail? Use a mechanical ventilator. These techniques have saved the lives of millions. There is a point of no return, however: when the brain dies.

One company, Philadelphia-based Bioquark Inc., thinks it may be possible to push back on even that last step. Bioquark plans to launch a study to use stem cells and a slew of other therapies to bring a glimmer of life back to the dead brains of newly deceased patients.

The idea led to hundreds of chilling headlines and has met serious backlash from scientists and ethicists alike. While Bioquarks proposed study may trigger ethical and practical concerns, experts do say advances in stem cell research and medical technologies mean someday brain injury could be reversible. Maybe (and thats a big maybe) brain death wont be the end of life.

I agree stem cell technology in the neurosciences has tremendous potential, but we have to study it in a way that makes sense, said Dr. Diana Greene-Chandos, assistant professor of neurosurgery and neurology at Ohio State University Wexner Medical Center. What doesnt make sense, she says, is to apply stem cell research in complex human brainsvery damaged onesbefore animal studies have gotten far enough.

Thats why Bioquarks proposed study, slated to take place in South America sometime this year, has caused such uproar in the science community. The team plans to administer therapies to 20 brain-dead subjects with the hope of stirring up electrical activity in the brain. The idea is to deliver stem cells to the brain and coax them to grow into new brain cells, or neurons, with the help of a nurturing peptide cocktail, electrical nerve stimulation, and laser therapy.

Related: Godlike 'Homo Deus' Could Replace Humans as Tech Evolves

We are employing this [combined] approach, using tools that by themselves have been employed extensively, but never in such an integrated process, said Bioquark CEO Ira Pastor.

One critique is that such a study could give false hope to families who may have a poor understanding of the severity and irreversibility of brain death, and confuse it with coma or vegetative state. There are a lot of gray areas in medicine. And we should all keep an open mind. But we need to make sure we are not misguiding our patients, said Dr. Neha Dangayach, attending physician in the neurosurgical intensive care Unit at New Yorks Mount Sinai Hospital.

Pastors response to the criticism? The public is catching up to the idea of brain death. Hes also clarified that full resurrection is not the companys intended goalat least not yet. We are not claiming the ability to erase death. We are working on a very small window, a gray zone between reversible coma and death, he said.

Ethics aside, critics say there are practical problems with the plan. There is insufficient evidence behind Bioquarks approach, they argue, and the way the study is planned does not sound realistic.

When the brain dies, inflammation and swelling run amok, the connections between neurons disintegrate, arteries collapse, and blood flow shuts down. Once someone is brain-dead, you can keep them on the ventilator but its very hard to keep the organs from shutting down and the heart beating for more than a few days, said neurologist Richard Senelick. Nature is going to run its course.

So, many scientists say Bioquarks study may be a quixotic queston par with cryogenic brain preservation and head transplants. They may sound good in theory but are so impractical that they have little chance of success. Nevertheless, experts agree the quest does raise serious questions that deserve answers. Just what would it take to save a brain? Perhaps resurrecting dead brains is not in the realm of possibilitybut what is?

There is an immense reward in pursuing brain regeneration. If it pans out, it could potentially save the lives of those who are injured in an accident or, more commonly, suffer extreme brain damage following a cardiac arrest or stroke. Every year in the United States, about 350,000 people experience an out-of-hospital cardiac arrest, according to the American Heart Association. Only about 10 percent survive with good neurologic function. Another 130,000 people die of stroke annually.

To appreciate the challenge of saving the brain, first look at what it takes to kill it. It was long thought that death occurs when the heart stops. Now we know that death actually happens in the brainand not in one single moment, but several steps. A patient lying in a coma in an intensive care unit may appear peaceful, but findings from biochemical studies paint a much different scene in his brain: fireworks at the cellular level.

When neurons encounter a traumatic event, like lack of blood flow after cardiac arrest, they go into a frenzy. Some cells die during the initial blackout. Others struggle to survive in the complex cascade of secondary injury mechanisms, triggered by the stress of being deprived of oxygen. Neurotransmitters spill out of neurons in high concentrations. Free radicals pile up, burning holes in brain cell membranes. The pierced cells respond to the attack by producing more inflammation, damaging other cells.

Eventually, the stress response triggers apoptosis, or the process of programmed cell death. In other words, the cells suicide switch gets turned on. The cells die one by one until the brain ceases to function.

Thats brain death: the complete and irreversible loss of function of the brain. Doctors determine brain death by checking whether the patient's pupils react to light, whether he responds to pain, and if his body tries to breathe or has retained any other vital function of the brainstem, the part most resilient to injury.

We have strict tests, because its a very serious questionthe question of distinguishing life from death, Dangayach said.

For brain damage at a much smaller scale, however, the situation could be manageable. Cutting-edge therapies are focused on this possibility.

Related: Three Myths About the Brain (That Deserve To Die)

Stem cells have brought an exciting potential opportunity to the grim area of treating brain injury. Currently, theres no FDA-approved stem cell-based therapy for brain problems, and experts suggest staying away from any clinic that offers such therapies. But that doesnt stop researchers from being excited about the possibilities. Unlike in other parts of the body, cells lost in the brain are gone forever. Could stem cells replace them?

That's a reasonable thing to ask, neurologist Dr. Ariane Lewis of New York University said. Lewis is a strong critic of Bioquarks approach, saying that the study borders on quackery, but she thinks stem cell research is promising for stroke recovery. We have little evidence right now, and this is not a commonly employed therapy, but its a research question.

Two regions in the adult brain contain stem cells that can give rise to new neurons, suggesting the brain has a built-in capacity to repair itself. Some of these cells can migrate long distances and reach the injury site.

In some injuries, the brain produces biological factors that stimulate stem cells. Researchers are working to identify those factorswith the aim of someday translating the findings into new drugs to boost a patient's own stem cells.

If we can identify factors that stimulate these cells we could directly repair [the brain], said Dr. Steven Kernie, chief of pediatric critical care medicine at New York Presbyterian Hospital, who is working on this research.

Other teams have been working on turning different types of brain cells into neurons. A team at Penn State University developed a cocktail of molecules that can convert glial cells, a type of brain cell, into functioning neurons in mice. The cocktail of molecules could be packaged into drug pills, the researchers said, perhaps one day taken by patients to regenerate neurons.

Another option: transplant new neurons into the brain. In a 2016 study, scientists successfully transplanted young neurons into damaged brains of mice. A real-life injury in the human brain is a much messier situation than a clear-cut lesion made in the lab. But eventually, such advances may translate into techniques to repair stroke damage.

Related: These Brain Boosting Devices Could Give Us Intelligence Superpowers

For diseases like Parkinsons, in which a particular population of neurons is lostas opposed to widespread indiscriminate damagethere have been several clinical trials with many more slated. Scientists in Australia are using brain cells of pigs as a substitute for lost neurons. Later this year, a Chinese clinical trial will implant young neurons derived from human embryonic stem cells into brains of Parkinsons patients. And five more groups are planning similar trials over the next two years, Nature reported.

Approaches taken in Parkinsons trials may be the most biologically plausible, Kernie said. If these trials are successful, they may pave the way for more widespread application of stem cells for treating brain diseases. Its not proven yet that it will work, but its something that's on the horizon.

FOLLOW NBC MACH ON TWITTER, FACEBOOK, AND INSTAGRAM.

Read the rest here:
These Scientists Have a Plan To Cheat Death. Will It Work? - NBCNews.com

Posted in New York Stem Cells | Comments Off on These Scientists Have a Plan To Cheat Death. Will It Work? – NBCNews.com

Tests show no signs of cancer for Danville 2-year-old – GoDanRiver.com

Posted: July 6, 2017 at 5:43 am

Two-year-old Nathan DeAndrea who underwent two stem cell transplants to treat neuroblastoma is free of cancer, according to his mother.

Testing last week that included a CT scan and a full-body scan showed no evidence of cancer, Shannon DeAndrea said during an interview at her home Monday morning.

No more cancer! said Nathans sister, 4-year-old Kailynn.

However, the DeAndreas are awaiting the results of a bone marrow biopsy performed on Nathan last week, Shannon said. Everyone is optimistic.

The doctor said he has never seen a bone marrow biopsy come back positive when everything else is clear, she said.

Results are expected this week, Shannon said.

Nathan was diagnosed with stage 4 neuroblastoma on Aug. 23, 2016. He had a tumor in his abdomen that spread to his bone marrow. He had spots on his skull, ribs and spine. He has had several rounds of chemotherapy, radiation and two stem cell transplants.

Neuroblastomas are cancers that begin in early nerve cells of the sympathetic nervous system, according to the American Cancer Society.

The scans results brought relief to Shannon and her family.

Its like I could breathe, she said.

As Kailynn put it, We said, hooray!

The next phase of treatment will include strengthening Nathans immune system. He will be in the hospital one week a month for six months, Shannon said.

Its to keep it [the cancer] from coming back, she said.

His immune system is still compromised. The genetic makeup of Nathans tumor put him at a higher risk of relapse, Shannon said.

Nathans first transplant included four or five days of chemo. The new stem cells following the chemo that killed off his old stem cells from the transplant were like a rescue, she said.

Its wiping you out and then giving you your cells back to restart your immune system, DeAndrea said.

A second round of heavy chemo was to try to kill what was left of the cancer and replenish cells, she said.

Nathans stem cell transplants were from his own cells, Shannon said.

Two types of stem cell transplants include autologous, which uses stem cells from the patients own body, and allogeneic using stem cells from another person.

The procedure is used for conditions including multiple myeloma, lymphoma, sickle cell anemia and leukemia, and other blood and immune disorders.

Stem cell transplants began in the late 50s/early 60s with the first successful procedure done in an identical twin. However, stem cell transplants were limited until medicines that prevent rejections became available.

The number of procedures increased in the 1980s.

Betsie Letterle, community engagement representative with BeTheMatch in Burlington, North Carolina, said there are more than 14 million bone marrow/stem cell donors in the BeTheMatch registry.

Bone marrow transplants traditionally involved taking the marrow from the back of the donors hip. But since then, weve progressed tremendously, Letterle said.

The newest way is to take stem cells from a vein in the donors arm, Letterle said. The donor receives an injection of medication to help their body manufacture a large amount of stem cells, she said.

Those are taken from the vein, similar to a plasma donation. Letterle said.

Anyone aged 18-44 can join the registry, but commitment is paramount among donors, she said.

Commitment is important because patients depend on us, Letterle said. We dont want anyone whos not really sure they could donate if called.

Only about one in 540 registered donors end up donating, she said. Everyone is an active donor until they turn 61, Letterle said.

Younger donors are healthier and make the most stem cells, she said.

We want to give the patient the optimum opportunity to get the best stem cells they can, she said.

If a donor comes up as a match, they will be asked for about 20-30 hours of their time over several weeks, Letterle said.

We work around the donors schedule, she said.

They get blood work done, and a physical to make sure theyre healthy enough to donate, Letterle said.

The donor never pays for anything, she said.

The doctor determines whether the procedure would be a stem cell or a traditional bone marrow transplant. That depends on the patients or recipients age and condition, Letterle said.

About 80 percent of registered donors are Caucasian, and BeTheMatch is looking for more minority donors, Letterle said. Many minority patients have trouble finding a match, she said.

The recipients blood type becomes whatever blood type the donor has, Letterle said.

Dr. William Clark with the Massey Cancer Center at Virginia Commonwealth University will speak about bone marrow and stem cell transplants from 11:30 a.m. to 1 p.m. July 11 at Ballou Recreation Center. A bone marrow/stem cell donor drive will also be held that day.

For more information on stem cell/bone marrow transplants, call Betsie Letterle at BeTheMatch at (877) 601-1926, ext. 7721.

JohnCrane reports for the Danville Register & Bee. Contact him atjcrane@registerbee.comor(434) 791-7987.

More:
Tests show no signs of cancer for Danville 2-year-old - GoDanRiver.com

Posted in Virginia Stem Cells | Comments Off on Tests show no signs of cancer for Danville 2-year-old – GoDanRiver.com

WCT selected to conduct Ph III NurOwn Trial in ALS – OutSourcing-Pharma.com

Posted: July 6, 2017 at 5:43 am

BrainStorm Cell Therapeutics has contracted Worldwide Clinical Trials (WCT) to conduct its planned Phase III study of NurOwn in the treatment of amyotrophic lateral sclerosis (ALS).

BrainStorm Cell Therapeutics is developing adult stem cell therapies derived from autologous bone marrow cells to treat neurodegenerative diseases.

According to New Jersey-based company, a study kick-off meeting is expected later this month.

The company has an exclusive, worldwide licensing agreement with Ramon, Tel Aviv Universitys technology transfer company, through which it holds the rights to develop and commercialize the NurOwn technology.

NurOwn previously demonstrated a clinically meaningful benefit of the technology in a randomized, double-blind, placebo-controlled clinical trial conducted in the US.

Subsequently, Brainstorm will conduct a randomized, double-blind, placebo-controlled multi-dose Phase III trial at multiple sites with support from WCT.

Chaim Lebovits, BrainStorm Cell Therapeutics CEO said selecting a contract research organization (CRO) is a critical step before initiating patient enrollment into the companys Phase III study of NurOwn.

See the original post:
WCT selected to conduct Ph III NurOwn Trial in ALS - OutSourcing-Pharma.com

Posted in New Jersey Stem Cells | Comments Off on WCT selected to conduct Ph III NurOwn Trial in ALS – OutSourcing-Pharma.com

Blood Drive To Honor 2 1/2-year-old Brain Tumor Patient, 4-year-old Lymphoma Patient – TAPinto.net

Posted: July 6, 2017 at 5:43 am

New Jersey Blood Services (NJBS), a division of New York Blood Center (NYBC), is asking the community to donate blood on Thursday, July 20 in honor of 2 1/2-year-old brain tumor victim, Gracie Skuches and 4-year-old Lymphoma patient, Alex Hammer. The Blood Drive in Honor of Grace & Alex will be held from 2pm - 8pm at the Knights of Columbus Hall, 79 Pascack Road, Township of Washington, NJ. Visit http://www.nybc.org and use group code 68937 to make an appointment. Walkins are also welcome.

The New York Blood Center has declared a Blood Emergency. With less than a days supply on hand of some blood types, NJBS is appealing to the community to donate in honor of Gracie and Alex and other cancer victims in area hospitals.

At 6 months old, Gracie was diagnosed with Atypical Teratoid/Rhabdiod Tumor (ATRT), an extremely rare, very difficult to treat pediatric brain tumor. In the United States, around 30 new ATRT cases are diagnosed each year or three children per 1,000,000.Pediatric brain cancer is the second leading cause of childhood death, just after leukemia.

Sign Up for E-News

Gracie has suffered many setbacks. Although her tumor was removed, it recurred in January, 2016 which caused facial paralysis. She has endured chemotherapy, a stem cell harvest, and three stem cell rescues. She is currently receiving maintenance chemo. During Gracies multiple surgeries and chemotherapies, she has received more than 20 blood transfusions and 20 platelet transfusions. Her family and friends are hopeful for a positive outcome.

Alexwas diagnosed with T-cell Lymphoblastic Lymphoma the day before Thanksgiving, 2016. He is currently being treated at Hackensack Children's Hospital and has been through multiple rounds of heavy chemotherapy with many platelet and red cell transfusions to support his treatment. Alexis in remission, although his treatment will last another two years as T-cell lymphoma is a very aggressive cancer. He is currently 4 years old.

Please Consider Donating Blood

New Jersey Blood Services is urging all healthy persons to donate on Thursday, July 20 from 2:00pm-8:00 pm at the Gracie and Alex Community Blood Drive. Eligible donors should be 17 years of age, or 16 with parental consent. A NYBC Donor Card or signed or photo ID must be presented prior to donating.

Approximately every two seconds, someone needs blood, and one out of three people will need a life-saving blood transfusion in their lifetime. If all eligible blood donors gave at least twice a year, it would greatly help in maintaining and adequate blood supply.

To make an appointment to donate or to run a blood drive in your community, call toll free: 1-800-933-BLOOD (2566).

Visit: http://www.nybloodcenter.org

About Blood Donations

The entire donation process takes less than an hour and a single donation can be used to save multiple lives. Donors with O-negative blood type, or universal donors, are especially encouraged to donate, as their blood can be used in emergencies. Nearly 2,000 donations are needed each day in New York and New Jersey alone. About one in seven hospital admissions requires a blood transfusion, and with a limited shelf life, supplies must be continually replenished.

If you cannot donate but still wish to participate in bringing crucial blood products to patients in need, please ask someone to donate for you, or consider volunteering at a local blood drive.

Any company, community organization, place of worship, or individual may host a blood drive. Blood donors receive free mini-medical exams on site including information about their temperature, blood pressure and hematocrit level. Eligible donors include those people at least age 16 (parental consent is required for 16-year-olds), who weigh a minimum of 110 pounds, are in good health and meet all Food & Drug Administration and NY or NJ State Department of Health donor criteria. People age 76 or older may donate if they have a doctors note on file with New York Blood Center or if they bring one on the day of the blood drive.

About New York Blood Center

Now more than 50 years old, New York Blood Center (NYBC) is a nonprofit organization that is one of the largest independent, community-based blood centers in the country. NYBCs mission is to serve the 20 million people in the New York/New Jersey metropolitan area and more broadly, our nation and our world by alleviating human suffering and preserving human life using our medical expertise.

Each year, NYBC provides approximately one million blood products to nearly 200 hospitals in the Northeast. NYBC also provides a wide array of transfusion-related medical services. NYBC is also home to the worlds largest public cord blood bank, which provides stem cells for transplant in many countries, and a renowned research institute, which among other milestones developed the hepatitis B vaccine and innovative blood purification technology.

Website: nybc.org

Facebook: http://www.facebook.com/newyorkbloodcenter

Twitter: @NYBloodCenter

Instagram: @newyorkbloodcenter

Go here to see the original:
Blood Drive To Honor 2 1/2-year-old Brain Tumor Patient, 4-year-old Lymphoma Patient - TAPinto.net

Posted in New Jersey Stem Cells | Comments Off on Blood Drive To Honor 2 1/2-year-old Brain Tumor Patient, 4-year-old Lymphoma Patient – TAPinto.net

Regenexx Las Vegas | Nevada’s Regenexx Provider

Posted: July 6, 2017 at 5:41 am

Select a Problem Area

If you have pain, we're here to help. Regenexx Procedures are patented stem cell and blood platelet procedures that are used to treat a wide range of joint and spine conditions.

Click a problem area to discover what Regenexx can do for you.

The Regenexx family of non-surgical stem-cell & blood platelet procedures are next generation regenerative injection treatments for those who are suffering from shoulder pain due to arthritis, rotator cuff and shoulder labrum tears, overuse injuries, and other degenerative conditions. Regenexx is also a viable alternative for those considering shoulder replacement surgery.

View Details About Shoulder Treatments

Commonly Treated Conditions:

Regenexx Procedures are advanced stem cell and blood platelet procedures for foot and ankle conditions. Before you consider ankle surgery, fusion or replacement, consider the worlds leading stem cell and prp injection treatments.

View Details About Foot & Ankle Treatments

Commonly Treated Conditions:

The Regenexx family of non-surgical stem-cell & blood platelet procedures are next generation regenerative injection treatments for those who are suffering from pain or reduced range of motion due to basal joint / cmc arthritis, hand arthritis, or other injuries & conditions in the hand.

View Details About Hand & Wrist Treatments

Commonly Treated Conditions:

The Regenexx family of non-surgical stem cell and blood platelet procedures offer next-generation injection treatments for those who are suffering from knee pain or may be facing knee surgery or knee replacement due to common injuries, arthritis, overuse and other conditions.

View Details About Knee Treatments

Commonly Treated Conditions:

The Regenexx family of non-surgical stem-cell & blood platelet procedures are next generation regenerative injection treatments for those who are suffering from pain, inflammation or reduced range of motion due tocommon elbow injuries, arthritis and overuse conditions.

View Details About Elbow Treatments

Commonly Treated Conditions:

The Regenexx family of hip surgery alternatives are breakthrough, non-surgical stem-cell treatments for people suffering from hip pain due to common injuries, hip arthritis & other degenerative problems related to the hip joint.

View Details About Hip Treatments

Commonly Treated Conditions:

Regenexx has many non-surgical platelet and stem cell based procedures developed to help patients avoid spine surgery and high dose epidural steroid side effects. These procedures utilize the patients own natural growth factors or stem cells to treat bulging or herniated discs, degenerative conditions in the spine, and other back and neck conditions that cause pain.

View Details About Spine Treatments

Commonly Treated Conditions:

Regenexx has many non-surgical platelet and stem cell based procedures developed to help patients avoid spine surgery and high dose epidural steroid side effects. These procedures utilize the patients own natural growth factors or stem cells to treat bulging or herniated discs, degenerative conditions in the spine, and other back and neck conditions that cause pain.

View Details About Spine Treatments

Commonly Treated Conditions:

Go here to read the rest:
Regenexx Las Vegas | Nevada's Regenexx Provider

Posted in Nevada Stem Cells | Comments Off on Regenexx Las Vegas | Nevada’s Regenexx Provider

Stem Cell Therapy Reno NV – Sierra Stem Cell Institute

Posted: July 6, 2017 at 5:41 am

AtSierra Stem Cell Institute in Reno, NV we are driven by a passion to help those suffering from chronic, painful, musculoskeletal conditions. We employ Stem Cell and Platelet Rich Plasmainjections to help patients avoid surgery and heal in a more natural manner. We have treated patients from all over the country, but typically serve the Northern Nevada and Northern California region.

Contact Us

Injections tailored to the orthopedic and spine problem. Learn More

Injections for various orthopedic joint problems, including spine problems. Learn More

Another powerful way of acquiring stem cells for injection therapy. Learn More

Knee arthritis Shoulder arthritis Ankle arthritis Rotator Cuff tendonitis and injuries Some knee injuries and sprains Ankle arthritis, sprains and injuries Facet arthritis of the spine Disc injuries of the spine SacroIliac arthritis, sprains and injuries

Decades of clinical experience showed us that a large group of patients are left struggling with pain and limited function, but their condition is not yet severe enough to warrant major surgery. Many patients do not obtain a satisfactory result with pain medications, chiropractic care, acupuncture, physical therapy, steroid injections, and other conservative treatments. In some cases, the outcomes for surgery are not consistently good. The emergence of biological therapies has opened up a wide variety of treatment options which can help patients avoid surgery, diminish pain, and restore function.

See the article here:
Stem Cell Therapy Reno NV - Sierra Stem Cell Institute

Posted in Nevada Stem Cells | Comments Off on Stem Cell Therapy Reno NV – Sierra Stem Cell Institute

Dynamic Stem Cell Therapy | Stem Cell Therapy Nevada

Posted: July 6, 2017 at 5:41 am

Stem cell therapy is the process of isolating adult stem cells from abdominal fat and reintroducing them into the body wherever they can do the most good. The process begins with extracting a few ounces of fat from the patient in a mini liposuction procedure. After the fat is removed, the stem cells are isolated using a state-of-the-art centrifuge. Once isolated, the stem cells are are then reintroduced to the body by IV and/or targeted injections for more localized treatments. Local treatments can help with knee, shoulder, and other joint pain. Stem cells can also be applied to the face, neck, and scalp using a micro-needle system to give you a healthy and youthful look. All treatments are outpatient procedures, conducted in a sterile environment at ouroffice, utilizing state-of-the-art equipment. The process is safe and relatively painless with minimal downtime.

Stem cells are the bodys raw materials or natural building block-cells from which all other cells with specialized functions are generated.

Stem cells can maintain and repair tissues. Stem cells are unique in that they have the potential to develop into many different types of cells. Stem cells can seek out areas that need repair or restoration. Our bodys natural healing process isreasonablyefficient, but modern science can now accelerate your regenerative process.

There are primarily two types of stem cells used for treatments: embryonic and adult stem cells.

Embryonic stem cells are derived from embryos. Adult stem cells can be derived from a patients own body. Adult stem cells exist throughout the body, however the most abundant, and themost accessible source is your own adipose fat.

Read more:
Dynamic Stem Cell Therapy | Stem Cell Therapy Nevada

Posted in Nevada Stem Cells | Comments Off on Dynamic Stem Cell Therapy | Stem Cell Therapy Nevada

Page 1,515«..1020..1,5141,5151,5161,517..1,5201,530..»